Acadia shares plunge on report FDA is re-examining its drug
April 25, 2018 at 14:53 PM EDT
Nuplazid, which treats psychosis associated with Parkinson's disease, has been scrutinized for reports of people dying while taking it.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.